Diagnosis and Management of Hepatitis
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Diagnostic Microbiology and Infectious Disease".
Deadline for manuscript submissions: closed (30 April 2022) | Viewed by 1920
Special Issue Editor
2. School of Medicine, National Yang-Ming University, Taipei 11221, Taiwan
Interests: hepatitis; diagnosis; SQSTM1; autophagy; subsites; tumorigenesis; prognosis; oral cancer; ATG4B; colorectal cancer
Special Issue Information
Dear Colleagues,
Chronic hepatitis virus infection is a major global health problem and cause of liver cirrhosis and hepatocellular carcinoma worldwide. After the introduction of direct acting antivirals (DAA), chronic hepatitis C virus (HCV) infection can be cured in around 98–99% of patients. Universal eradication of HCV is the goal of Hepatologists worldwide. To date, only nucleos(t)ide analogues (NA) have been approved for the treatment of chronic hepatitis B virus (HBV) infection. NA inhibits polymerase of HBV and can effectively suppress HBV DNA but has little effect on the synthesis of cccDNA. Once NA treatment is stopped, relapse of HBV is universal. Cure of HBV remains a clinical challenge. The clinical benefits of different NAs in treating chronic HBV infection remain controversial. The diagnosis of chronic viral infection requires the identification of viral genomes in molecular studies. Different forms of viral genomes or antigens may be associated with the outcome of chronic hepatitis. Submissions regarding the diagnosis and management of hepatitis are welcome for this Special Issue.
Dr. Weilun Tsai
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
